XML 17 R6.htm IDEA: XBRL DOCUMENT v3.25.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (UNAUDITED) - USD ($)
shares in Thousands, $ in Thousands
Common Stock
Class A Common shares
Common Stock
Class B Common shares
Common Stock
Additional Paid In Capital
Retained Earnings
Class A Common shares
Retained Earnings
Class B Common shares
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Class A Common shares
Class B Common shares
Total
Balance at beginning of period at Dec. 31, 2023     $ 4,553 $ 142,124     $ 786,487 $ (20,408)     $ 912,756
Balance (in shares) at Dec. 31, 2023 17,203 2,155                  
Increase (Decrease) in Stockholders' Equity                      
Net income             30,606       30,606
Net change in AOCI               486     486
Dividends declared on Common Stock:                      
Dividends declared on Common Stock         $ (6,986) $ (796)     $ (6,986) $ (796)  
Stock options exercised, net of shares withheld     26 (689)     (437)       (1,100)
Stock options exercised, net of shares withheld (in shares) 37                    
Conversion of Class B to Class A Common Shares (in shares) 4 (4)                  
Deferred director compensation expense - Class A Common Stock     (1) 135             134
Deferred designed key employee compensation expense - Class A Common Stock       167             167
Deferred designed key employee compensation expense - Class A Common Stock (In shares) 11                    
Employee stock purchase plan - Class A Common Stock     1 183             184
Employee stock purchase plan - Class A Common Stock (in shares) 4                    
Stock-based awards, Performance stock units       36             36
Stock-based awards, Restricted stock, net of shares withheld     (1) (34)     (38)       (73)
Stock-based awards, Restricted stock, net of shares withheld (in shares) 1                    
Stock-based awards, Stock options       169             169
Balance at end of period at Mar. 31, 2024     4,578 142,091     808,836 (19,922)     935,583
Balance (in shares) at Mar. 31, 2024 17,260 2,151                  
Balance at beginning of period at Dec. 31, 2024     4,587 148,053     853,627 (14,238)     992,029
Balance (in shares) at Dec. 31, 2024 17,298 2,150                  
Increase (Decrease) in Stockholders' Equity                      
Net income             47,268       47,268
Net change in AOCI               2,573     2,573
Dividends declared on Common Stock:                      
Dividends declared on Common Stock         $ (7,799) $ (882)     $ (7,799) $ (882)  
Stock options exercised, net of shares withheld     8 2,671     (2,304)       375
Stock options exercised, net of shares withheld (in shares) 36                    
Net change in notes receivable on Class A Common Stock       (48)             (48)
Deferred director compensation expense - Class A Common Stock       143             143
Deferred designed key employee compensation expense - Class A Common Stock     (1) 269     (179)       89
Deferred designed key employee compensation expense - Class A Common Stock (In shares) 18                    
Employee stock purchase plan - Class A Common Stock     1 176             177
Employee stock purchase plan - Class A Common Stock (in shares) 3                    
Stock-based awards, Performance stock units       36             36
Stock-based awards, Restricted stock, net of shares withheld     (1) 17     (44)       (28)
Stock-based awards, Restricted stock, net of shares withheld (in shares) 13                    
Stock-based awards, Stock options       156             156
Balance at end of period at Mar. 31, 2025     $ 4,594 $ 151,473     $ 889,687 $ (11,665)     $ 1,034,089
Balance (in shares) at Mar. 31, 2025 17,368 2,150